1 | 2 | 3 | 4 Contact Login Grünenthal Worldwide DE / EN Company Products Research & Development Patients Media Partnering Jobs & Career Headquarters Grünenthal Group Zieglerstraße 6 52078 Aachen Germany Phone: +49 241 569-0 Contact Form Adverse Drug Reaction Reporting This site complies with the HONcode standard for trustworthy health information: verify here. Grünenthal Group The Grünenthal Group The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. These investments amounted to about 20 percent of revenues in 2014. Read more... Zalviso® 15 micrograms sublingual tablets Grünenthal receives EU Marketing Authorization for Zalviso® 15 micrograms sublingual tablets Grünenthal has received EU marketing authorization for Zalviso® 15 micrograms sublingual tablets for the management of acute moderate to severe post-operative pain in adult patients. With this, Grünenthal will enter the European hospital market and further build its leading position in the area of pain therapy innovation. The marketing authorization is granted for the 28 EU member states as well as Norway, Iceland and Liechtenstein, and the product will available in the first half of 2016. Grünenthal has in-licensed Zalviso® from AcelRx Pharmaceuticals Inc. for Europe and Australia. Read more... You are... Physician or Pharmacist Journalist Applicant Patient Initiatives CHANGE PAIN® My Pain Feels Like... EFIC-Grünenthal Grant Societal Impact of Pain About us Facts and Figures Management Research & Development Affiliates worldwide Life at Grünenthal Discover Grünenthal Explore Careers Service Contact Reporting side effects Sitemap Print Grünenthal 2021 © Imprint Privacy Statement Disclaimer General Terms and Conditions